ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves

Key Takeaways ANGO posted flat adjusted EPS in Q2, beating expectations as pro-forma revenue grew 8.8% to $79.4M.ANGO's pro forma gross margin expanded 170 bps to 56.4% on improved mix and manufacturing optimization.ANGO raised FY26 sales guidance to $312-$314M, led by 13% Med Tech growth and solid U.S. demand.AngioDynamics, Inc. (ANGO) reported breakeven adjusted earnings per share for second-quarter fiscal 2026, marking an improvement from the year-ago quarter’s adjusted loss of 4 cents. The Zacks Consens ...